Fast recruiting clinical trials – a Utopian dream or logistical nightmare?

por Johnson, L, Ellis, P, Bliss, J M
Publicado 2005

A method for assessing the quality of life of cancer patients: replication of the factor structure.

por Bliss, J. M., Selby, P. J., Robertson, B., Powles, T. J.
Publicado 1992

How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients

por Johnson, L, Barrett-Lee, P, Ellis, P, Bliss, J M
Publicado 2008

Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?

por Bhattacharya, I.S., Kirby, A.M., Bliss, J.M., Coles, C.E.
Publicado 2018

Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer

por Mills, J., Haviland, J.S., Moynihan, C., Bliss, J.M., Hopwood, P.
Publicado 2018

Analgesics in cancer pain: current practice and beliefs.

por White, I. D., Hoskin, P. J., Hanks, G. W., Bliss, J. M.
Publicado 1991

Oral contraceptives and survival in breast cancer.

por Millard, F. C., Bliss, J. M., Chilvers, C. E., Gazet, J. C.
Publicado 1987

Influence of delay in diagnosis on prognosis in testicular teratoma.

por Chilvers, C. E., Saunders, M., Bliss, J. M., Nicholls, J., Horwich, A.
Publicado 1989

Bone marrow micrometastases in early breast cancer–30-year outcome

por Mansi, J, Morden, J, Bliss, J M, Neville, M, Coombes, R C
Publicado 2016

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.

por Lakhani, S., Selby, P., Bliss, J. M., Perren, T. J., Gore, M. E., McElwain, T. J.
Publicado 1990

4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.

por Coombes, R. C., Wilkinson, J. R., Bliss, J. M., Shah, P., Easton, D. F., Dowsett, M.
Publicado 1991

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.

por Shah, P., van der Meide, P. H., Borman, T., Schroeder, N., Bliss, J. M., Coombes, R. C.
Publicado 1989

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation

por Fallowfield, L J, Kilburn, L S, Langridge, C, Snowdon, C F, Bliss, J M, Coombes, R C
Publicado 2012

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma

por Horwich, A, Fossa, S D, Huddart, R, Dearnaley, D P, Stenning, S, Aresu, M, Bliss, J M, Hall, E
Publicado 2014

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for e...

por Hall, E., Cameron, D., Waters, R., Barrett-Lee, P., Ellis, P., Russell, S., Bliss, J.M., Hopwood, P.
Publicado 2014

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane ve...

por Bertelli, G., Hall, E., Ireland, E., Snowdon, C. F., Jassem, J., Drosik, K., Karnicka-Mlodkowska, H., Coombes, R. C., Bliss, J. M.
Publicado 2010

Biomarker-guided trials: Challenges in practice

por Antoniou, M., Kolamunnage-Dona, R., Wason, J., Bathia, R., Billingham, C., Bliss, J.M., Brown, L.C., Gillman, A., Paul, J., Jorgensen, A.L.
Publicado 2019

Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.

por Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rahman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., Bliss, J. M., Stratton, M. R., Yarnold, J.
Publicado 1998

Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?

por Leonard, R, Ballinger, R, Cameron, D, Ellis, P, Fallowfield, L, Gosney, M, Johnson, L, Kilburn, L S, Makris, A, Mansi, J, Reed, M, Ring, A, Robinson, A, Simmonds, P, Thomas, G, Bliss, J M
Publicado 2011

Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial

por Sipos, O., Tovey, H., Quist, J., Haider, S., Nowinski, S., Gazinska, P., Kernaghan, S., Toms, C., Maguire, S., Orr, N., Linn, S.C., Owen, J., Gillett, C., Pinder, S.E., Bliss, J.M., Tutt, A., Cheang, M.C.U., Grigoriadis, A.
Publicado 2021